@drkjoseph1

1 post audited · 6 claims analysed

Instagram profile

Science evidence grade

100%High evidence grade

Based on 6 claims across 1 audit

SupportedOverstatedMisleadingNo Evidence

6

Supported

100%

0

Overstated

0%

0

Misleading

0%

0

No Evidence

0%

Share this evidence grade

Claim-level evidence grades — not a character judgment. Methodology · Right of reply · Leaderboards

What @drkjoseph1 claims actually are

We separate claims into three buckets: backed by evidence, factually incorrect, and grey — like animal-only findings sold as human fact (e.g. BPC-157 “fixes Achilles” from rat studies).

Evidence-based

100%

6 claims

Claims that align with published human or clinical evidence at the stated strength.

Ex: “Semaglutide can reduce body weight in adults with obesity” — supported by large RCTs.

Factually incorrect

0%

0 claims

Claims that conflict with the evidence, invent certainty, or omit critical safety/context in a misleading way.

Ex: “Peptides have no side effects” — contradicts known adverse-event profiles.

Grey / overstated

0%

0 claims

Plausible direction but wrong certainty — animal-only data sold as human fact, dose/effect overstated, or no adequate published support yet.

Ex: “BPC-157 fixes Achilles tears” — often rests on rodent tendon models, not proven human Achilles repair trials.

Evidence mix

Share of audited claims in each bucket

Loading…
BackedIncorrectGrey

Verdict detail

Grey splits into overstated (wrong certainty) vs no published support

Loading…

Claims over time

Stacked by bucket as audits land — plus the running evidence grade

Loading…

Gold line = running science evidence grade (Supported + ½ Overstated ÷ total claims).

Audit history(1 post)

Post thumbnail
✅ Supported
Posted Sep 10, 2026·2 months ago·View post

“You're Using MOTS-c WRONG — Here's What Actually Works (Dr. Explains) Want my exact peptide protocols? https://www.drkjoseph.com/peptide-blueprint-a635ac86-e08c-4789-9f80-1a6cf09a2dacMost MOTS-c protocols get one thing wrong: d...”

All six claims about MOTS-c are supported by preclinical scientific evidence (animal models and cell-based studies). MOTS-c is confirmed as a mitochondrial-derived peptide with documented exercise-responsiveness and metabolic effects mediated through AMPK activation, including enhanced fat oxidation and glucose uptake via GLUT4 mechanisms. Evidence tier is primarily animal/in-vitro; human clinical trials are not yet available, so claims should be understood as mechanistically plausible and preclinically validated rather than clinically proven. The creator's characterization aligns accurately with the current state of peer-reviewed MOTS-c research.

Audit another post from @drkjoseph1

Paste their social post link to add a new audit

New audit